R&G Pharma plans to launch an employee stock ownership plan in 2025 with a total funding not exceeding 15 million yuan
I'm PortAI, I can summarize articles.
R&G Pharma plans to implement an employee stock ownership plan in 2025, with a total funding amount not exceeding 15 million yuan. The funding sources include the company's reward fund and other legal means. The planned stock scale is not more than 385,800 shares, with a repurchase price of 38.88 yuan per share, and a duration of 36 months
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments